• 1
    Wen PY, Black PM, Loeffler JS. Metastatic brain cancer. In: DeVitaV, HellmanS, RosenbergSA, editors. Cancer: principles and practice of oncology. 6th ed. Philadelphia: Lippincott, Williams & Wilkins; 2001: 26552670.
  • 2
    Greenberg H, Chandler WF, Sandler HM. Brain metastases. In: GreenbergH, ChandlerWF, SandlerHM, editors. Brain tumors. New York: Oxford University Press; 1999: 299317.
  • 3
    Mehta MP, Tremont-Lukats I. Radiosurgery for single and multiple brain metastasis. In: SawayaR, editor. Intracranial metastases: current management strategies. Malden, Mass: Blackwell Publishing, Futura Division; 2004: 139164.
  • 4
    Van den Hout WB, Van der Linden YM, Steenland E, et al. Single- versus multiple-fraction radiotherapy in patients with painful bone metastases: cost-utility analysis based on a randomized trial. J Natl Cancer Inst. 2003; 95: 222229.
  • 5
    Zimm S, Wampler GL, Stablein D, Hazra T, Youg HF. Intracerebral metastases in solid tumor patients: natural history and results of treatment. Cancer. 1981; 48: 384394.
  • 6
    Sundstrom JT, Minn H, Lertola KK, Nordman E. Prognosis of patients treated for intracranial metastases with whole-brain irradiation. Ann Med. 1998; 30: 296299.
  • 7
    Gaspar L, Scott C, Rotman M, et al. Recursive partitioning analysis (RPA) of prognostic factors in three Radiation Therapy Oncology Group (RTOG) brain metastases trials. Int J Radiat Oncol Biol Phys. 1997; 37: 745751.
  • 8
    Kurtz JM, Gelber R, Brady LW, Carella LJ, Cooper JS. The palliation of brain metastases in a favorable patient population: a randomized clinical trial by the Radiation Therapy Oncology Group. Int J Radiat Oncol Biol Phys. 1981; 7: 891895.
  • 9
    Chatani M, Matayoshi Y, Masaki N, Inoue T. Radiation therapy for brain metastases from lung carcinoma. Prospective randomized trial according to the level of lactate dehydrogenase. Strahlenther Onkol. 1994; 170: 155161.
  • 10
    Murray KJ, Scott C, Greenberg HM, et al. A randomized phase III study of accelerated hyperfractionation versus standard in patients with unresected brain metastases: a report of the Radiation Therapy Oncology Group (RTOG) 9104. Int J Radiat Oncol Biol Phys. 1997; 39: 571574.
  • 11
    Kaplan EL, Meier P. Non parametric estimation from incomplete observations. J Am Stat Assoc. 1958; 53: 457481.
  • 12
    Eyre HJ, Ohlsen JD, Frank J, et al. Randomized trial of radiotherapy versus radiotherapy plus metronidazole for the treatment of metastatic cancer to the brain. J Neurooncol. 1984; 2: 325330.
  • 13
    DeAngelis LM, Currie VE, Kim JH, et al. The combined use of radiation therapy and loniamide in the treatment of brain metastases. J Neurooncol. 1989; 7: 241247.
  • 14
    Komarnicky LT, Phillips TL, Martz K, Asbell S, Isaacson S, Urtasun R. A randomized phase III protocol for the evaluation of misonidazole combined with radiation in the treatment of patients with brain metastases (RTOG-7916). Int J Radiat Oncol Biol Phys. 1991; 20: 5358.
  • 15
    Mehta MP, Rodrigus P, Terhaard CH, et al. Survival and neurologic outcomes in a randomized trial of motexafin gadolinium and whole-brain radiation therapy in brain metastases. J Clin Oncol. 2003; 21: 25292536.
  • 16
    Ushio Y, Arita N, Hayakawa T, et al. Chemotherapy of brain metastases from lung carcinoma: a controlled randomized study. Neurosurgery. 1991; 28: 201205.
  • 17
    Postmus PE, Haaxma-Reiche H, Smit EF, et al. Treatment of brain metastases of small-cell lung cancer: comparing teniposide and teniposide with whole brain radiotherapy—a phase II study of the European Organization for the Research and Treatment of Lung Cancer Cooperative Group. J Clin Oncol. 2000; 18: 34003408.
  • 18
    Robinet G, Thomas P, Breton JL, et al. Results of a phase III study of early versus delayed whole brain radiotherapy with concurrent cisplatin and vinorelbine combination for inoperable brain metastasis of non-small cell lung cancer: Groupe Francaise de Pneumo-Cancerologie (GFPC) protocol 95-1. Ann Oncol. 2001; 12: 5967.
  • 19
    Antonadou D, Coliarakis N, Paraskevaidis M, et al. Whole brain radiotherapy alone or in combination with temozolamide for brain metastases. A phase III study. Int J Radiat Oncol Biol Phys. 2002; 54: 93. Abstract.
  • 20
    Mornex F, Thomas L, Mohr P, et al. Randomized phase III trial of fotemustine plus whole brain irradiation in cerebral metastases of melanoma. Cancer Radiother. 2003; 7: 18.
  • 21
    Joiner MC, Van der Kogel AJ. The linear-quadratic approach to fractionation and calculation of isoeffect relationships. In: SteelGG, editor. Basic clinical radiobiology. New York: Oxford University Press; 1997: 106112.
  • 22
    DeAngelis LM, Delattre JY, Posner JB. Radiation-induced dementia in patients cured of brain metastases. Neurology. 1989; 39: 789796.